n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with Aging in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altar, CA; Kikuchi, T; Miwa, T; Nakai, M; Oshiro, Y; Tottori, K; Uwahodo, Y; Yamada, S | 1 |
1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and Aging
| Article | Year |
|---|---|
Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Anisoles; Avoidance Learning; Brain Chemistry; Cholinergic Agents; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Male; Maze Learning; Memory Disorders; Microdialysis; Muscarinic Antagonists; Piperazines; Propylamines; Quinolones; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, sigma; Scopolamine; Serotonin Receptor Agonists | 2002 |